Newsletter Subject

Did the Dobbs Decision Impact Maternal Death Rates?

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Tue, Aug 27, 2024 10:44 PM

Email Preheader Text

Daily Headlines Tuesday, August 27, 2024 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLIGHT

[MEDPAGE TODAY]( Daily Headlines Tuesday, August 27, 2024 Today's Top Stories for {NAME} [OB/GYN]( [Did the Dobbs Decision Impact Maternal Death Rates?]( [INFECTIOUS DISEASE]( [West Nile and EEE: What to Know About Mosquito-Borne Illness in the U.S.]( [INFECTIOUS DISEASE]( [Blood Culture Bottle Shortage Starting to Ease, Becton Dickinson Says]( THE BREAK ROOM [Spell Check-Up: Try to Pass This Spelling Quiz]( CME SPOTLIGHT [Integrating Novel Bispecific Antibody Therapies Into Treatment Paradigms in Relapsed/Refractory Follicular Lymphoma]( [PSYCHIATRY]( [Antidepressants May Reduce Risk of Falls in Older Adults]( [GASTROENTEROLOGY]( [Lasting Reductions in CRC Incidence, Death With Single Sigmoidoscopy]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [CARDIOLOGY]( [Clot Grabber IFU Recall; Free Cholesterol Tests at CVS; Naloxone for Cardiac Arrests]( CME SPOTLIGHT [Collaborative Care for Integrating CAR T-cell Therapy Into CLL Care]( [PERSPECTIVES]( [We're Missing Opportunities to Help Pregnant Patients Navigate Environmental Threats]( [ENDOCRINOLOGY]( [T1D Stem Cell Success Story; Lilly's Discount Tirzepatide Vials; Stelo Now Available]( [RHEUMATOLOGY]( [Novel Drug Works Near-Miracle for sJIA Patients With Life-Threatening Complication]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Decoding Indolent Systemic Mastocytosis: A Deep Dive Into Pathophysiology, Recognition, and Evidence-Based Diagnosis]( [PERSPECTIVES]( [Geisinger Health System: A Bellwether for Value-Based Care]( [ONCOLOGY/HEMATOLOGY]( [Mixed Results With Cyclophosphamide in Mismatched Unrelated Stem Cell Transplants]( [PEDIATRICS]( [Maternal PCOS Linked to Growth Restriction in Newborns]( CME SPOTLIGHT [Maximizing Multiple Myeloma Care: What Hematology/Oncology Teams Need to Know About Bispecific Antibodies]( [INFECTIOUS DISEASE]( [FDA Could Soon Limit Use of Only Drug for COVID Prevention]( [PRIMARY CARE]( [Ultraprocessed Foods Are Everywhere. How Bad Are They?]( [INFECTIOUS DISEASE]( [White House Pressured Facebook to 'Censor' Some COVID Content, Mark Zuckerberg Says]( CME SPOTLIGHT [Adjuvant Endocrine Therapy in HR+ Breast Cancer: Enhancing Quality Care and Patient Outcomes]( [PERSPECTIVES]( [Medical Needs of Paralympic vs Olympic Athletes]( [ENDOCRINOLOGY]( [FDA Clears First Automated Insulin-Delivery Tech for Type 2 Diabetes]( [MEDICAL JOURNEYS]( [For Your Patients: Understanding Progressive MS and Relapsing MS]( CME SPOTLIGHT [Navigating Endocrine Resistance: Latest Strategies in HR+/HER2- Breast Cancer Care]( [MEDICAL JOURNEYS]( [How Progressive Multiple Sclerosis Differs From Relapsing-Remitting MS]( # Weekly Survey [Do You Trust Compounded Drugs?]( More people are [turning to compounded weight-loss drugs]( in the wake of medication shortages[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2024-08-27&mh=3c4cdd242849aa0e970f25e401732f81) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.